Pruritus Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), By Product (Corticosteroids, Antihistamines), By Region, And Segment Forecasts, 2023 - 2030

Report
80 Pages
August 2023
Region: Global
Grand View Research
ID: 5876216

The global pruritus therapeutics market size is expected to reach USD 11.38 billion by 2030, registering a CAGR of 4.0% from 2023 to 2030. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria is expected to drive market growth during the forecast period. The introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period.

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.

Pruritus Therapeutics Market Report Highlights

Calcineurin inhibitor is identified as the most lucrative segment of the market on account of the high usage rate of these drugs in combination therapy for the treatment of pruritus in patients suffering from chronic pruritus and growing market penetration rates. Moreover, the introduction of new products such as Pimecrolimus cream and Tacrolimus ointment is expected to further drive this market.
Anti-histamines owing to its growing use as a first-line treatment and presence of drugs in pipeline with expected commercialization is also expected to grow at a healthy rate during the forecast period.
North America dominated the market and accounted for the largest revenue share of 39.9% in 2022. majorly on account of the presence of a high prevalence of diseases associated with pruritus, the introduction of new products targeting the unmet medical needs, and growing patient awareness levels.
The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of over 5.0% during the forecast period. The presence of high unmet healthcare needs and increasing prevalence of allergic contact dermatitis and urticaria in this region are some factors attributing to its rapid growth rate.
Manufacturers adhere to rigorous R&D in an attempt to develop cost-effective products and avoid barriers such as product recalls. In addition, this strategy is implemented keeping the unmet needs into consideration. For Instance, Creabilis has a molecule in the pipeline - CT327, which caters to the unmet needs associated with pruritus in patients suffering from psoriasis.

This product will be delivered within 1-3 business days.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Disease type
1.1.2. Product
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease Type Outlook
2.2.2. Product Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights

Chapter 3. Pruritus Therapeutics Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Pruritus Therapeutics Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Pruritus Therapeutics: Disease Type Estimates & Trend Analysis

4.1. Pruritus Therapeutics Market: Key Takeaways
4.2. Pruritus Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Atopic Dermatitis
4.3.1. Atopic dermatitis market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Allergic Contact Dermatitis
4.4.1. Allergic contact dermatitis market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Urticaria
4.5.1. Urticaria market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Others
4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Pruritus Therapeutics: Product Estimates & Trend Analysis

5.1. Pruritus Therapeutics Market: Key Takeaways
5.2. Pruritus Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Corticosteroids
5.3.1. Corticosteroids market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Antihistamines
5.4.1. Antihistamines market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Local Anesthetics
5.5.1. Local anesthetics market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Counterirritants
5.6.1. Counterirritants market estimates and forecasts, 2018 to 2030 (USD Billion)
5.7. Immunosuppressant
5.7.1. Immunosuppressant market estimates and forecasts, 2018 to 2030 (USD Billion)
5.8. Calcineurin Inhibitors
5.8.1. Calcineurin inhibitors market estimates and forecasts, 2018 to 2030 (USD Billion)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Pruritus Therapeutics Market: Regional Estimates & Trend Analysis

6.1. Regional Outlook
6.2. Pruritus Therapeutics Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7. Middle East & Africa
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbvie, Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Actavis Plc
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Amgen, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Astellas Pharma
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Bristol-Myers Squibb
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Cara Therapeutics
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. GlaxoSmithKline, Plc.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Myaln NV
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Novartis AG
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Pfizer Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Sanofi
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Teva Pharmaceuticals
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 3 North America pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 4 North America pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 5 U.S. pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 6 U.S. pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 7 Canada pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 8 Canada pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 9 Europe pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 10 Europe pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 11 Europe pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 12 Germany pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 13 Germany pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 14 UK pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 15 UK pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 16 France pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 17 France pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 18 Italy pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 19 Italy pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 20 Spain pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 21 Spain pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 22 Sweden pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 23 Sweden pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 24 Norway pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 25 Norway pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 26 Denmark pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 27 Denmark pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 28 Asia Pacific pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 29 Asia Pacific pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 30 Asia Pacific pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 31 Japan pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 32 Japan pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 33 China pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 34 China pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 35 India pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 36 India pruritus therapeutics market, by product, (USD Billion) 2018 - 2030
Table 37 Australia pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 38 Australia pruritus therapeutics market, by product, (USD Billion) 2018 - 2030
Table 39 Thailand pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 40 Thailand pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 41 South Korea pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 42 South Korea pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 43 Latin America pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 44 Latin America pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 45 Latin America pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 46 Brazil pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 47 Brazil pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 48 Mexico pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 49 Mexico pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 50 Argentina pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 51 Argentina pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 52 Middle East and Africa pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 53 Middle East and Africa pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 54 Middle East and Africa pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 55 South Africa pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 56 South Africa pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 57 Saudi Arabia pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 58 Saudi Arabia pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 59 UAE pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 60 UAE pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 61 Kuwait pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 62 Kuwait pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Pruritus therapeutics: Market outlook
Fig. 9 Pruritus therapeutics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Pruritus therapeutics market driver impact
Fig. 15 Pruritus therapeutics market restraint impact
Fig. 16 Pruritus therapeutics market strategic initiatives analysis
Fig. 17 Pruritus therapeutics market: Disease type movement analysis
Fig. 18 Pruritus therapeutics market: Disease type outlook and key takeaways
Fig. 19 Atopic dermatitis market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 20 Allergic contact dermatitis market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 Urticaria market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Pruritus therapeutics market: Product movement analysis
Fig. 24 Pruritus therapeutics market: Product outlook and key takeaways
Fig. 25 Corticosteroids market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 26 Antihistamines market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Local anesthetics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Counterirritants market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Immunosuppressant market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 30 Calcineurin inhibitors market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Global pruritus therapeutics market: Regional movement analysis
Fig. 33 Global pruritus therapeutics market: Regional outlook and key takeaways
Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Europe. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Companies Mentioned

Abbvie, Inc.
Actavis Plc
Amgen, Inc.
Astellas Pharma
Bristol-Myers Squibb
Cara Therapeutics
GlaxoSmithKline, Plc.
Myaln NV
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceuticals

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	80
Published	August 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 8.39 Billion
Forecasted Market Value ( USD ) by 2030	$ 11.38 Billion
Compound Annual Growth Rate	4.0%
Regions Covered	Global
No. of Companies Mentioned	12

PURCHASE OPTIONS

Single User License PDF

1 - 5 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5752EUR$5,950USD£4,944GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6719EUR$6,950USD£5,775GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8652EUR$8,950USD£7,437GBP

Pruritus Therapeutics Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Pruritus Therapeutics Market by Therapy (Antihistamines, Calcineurin Inhibitors, Corticosteroids), Disease Indication (Allergic Contact Dermatitis, Atopic Dermatitis, Cutaneous T-cell), Distribution Channel - Forecast 2024-2030

Pruritus Therapeutics Global Market Report 2024

Global Pruritus Therapeutics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers), By Regional Outlook and Forecast, 2023 - 2030

Global Pruritus Drugs Market Report and Forecast 2024-2032

Pruritus Therapeutics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030